https://www.selleckchem.com/pr....oducts/plumbagin.htm
In contrast, health professionals had reservations about the LoDED strategy, including concern about identifying low-risk patients and a shortened patient observation period. Findings from 11 patient interviews and 2 staff focus groups (with 20 clinicians) centred around three overarching themes acceptability of the LoDED strategy, perceptions of symptom severity and uncertainty, and patient discharge information. Rapid discharge for low-risk chest pain is acceptable to patients, but clinicians reported some reticence in implementing
Curtir
Comentario
Compartilhar
